You just read:

Synthetic Biologics Announces Rhonda Voskuhl, M.D., to Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results at the 2014 AAN Annual Meeting

News provided by

Synthetic Biologics, Inc.

Feb 10, 2014, 07:00 ET